Evaluation of the drug by Canadian regulatory authorities is under way. Paladin Labs will take over distribution of BTG’s treatment for digoxin toxicity or overdose in Canada. DigiFab™ is currently ...
Melville, NY - Savage Laboratories has announced the introduction of DigiFab? (digoxin immune fab [Ovine]), a digoxin toxicity antidote, to the US marketplace. The drug has been determined by the FDA ...
Protherics of the UK says that it has put forward a New Drug Submission to the Health Products and Food Branch of Health Canada for DigiFab, its digoxin toxicity drug. Protherics of the UK says that ...
Oct. 25, 2010, 9:15 AM EDT / Source: GlobeNewswire SOMERSET, N.J., Oct. 25, 2010 (GLOBE NEWSWIRE) -- inVentiv Commercial, a division of inVentiv Health and the industry leader in outsourced sales ...
Digoxin toxicity is a life-threatening condition. The most common symptoms are gastrointestinal and include nausea, vomiting, abdominal pain and diarrhea. The cardiac manifestations are concerning and ...
WASHINGTON, DC — Prescriptions for digoxin to patients discharged with reduced ejection-fraction (EF) heart failure fell by two-thirds over the 10 years ending in 2014, independent of age, sex, and ...